“School of Cognitive Sciences”

Back to Papers Home
Back to Papers of School of Cognitive Sciences

Paper   IPM / Cognitive Sciences / 8577
School of Cognitive Sciences
  Title:   Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test
  Author(s): 
1.  M.R. Zarrindast
2.  K. Kangarlu Haghighi
3.  A. khalighzadeh
4.  S. Fazli Tabaei
  Status:   Published
  Journal: Behavioral Pharmacology
  Vol.:  17
  Year:  2006
  Pages:   231-237
  Supported by:  IPM
  Abstract:
The effects of cannabinergic drugs on morphine state-dependent memory of passive avoidance task were examined in mice. Pre-training (0.25, 0.5 and 5 mg/kg) and post-training (5 mg/kg) administration of morphine impaired memory retrieval on the test day. Impairment of memory retrieval by morphine (5 mg/kg) on the test day was reversed by pre-test administration of the same dose of the opioid. The pre-test intracerebroventricular administration of the cannabinoid CB1/CB2 receptor agonist (WIN55, 212-2) (0.75 and 1 lg/mouse) not only mimicked the effect of pre-test morphine treatment, but also increased this action of the opioid. Furthermore, the pre-test intracerebroventricular administration of CB1 receptor antagonist (AM251) (20 and 100 ng/mouse) prevented the restoration of memory by morphine. Pre-training administration of WIN55, 212-2 (1 lg/mouse) led to state-dependent learning with impaired memory retrieval on the test day as well, which was reversed by pre-test administration of the drug (0.5, 0.75 and 1 lg/mouse) or morphine (1 and 5 mg/kg). Restoration of impairment induced by WIN55, 212-2 was decreased by the opioid receptor antagonists, naloxone (0.01 lg/mouse) and AM251 (20 and 100 ng/mouse). In conclusion, the improvement of memory retrieval by morphine treatment on the test day seems to be induced, at least in part, by the cannabinoid CB1 receptors.

Download TeX format
back to top
scroll left or right